-
1
-
-
78650717087
-
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
-
Early Breast Cancer Trialists' Collaborative Group
-
Early Breast Cancer Trialists' Collaborative Group. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010(41):162-177.
-
(2010)
J Natl Cancer Inst Monogr.
, vol.2010
, Issue.41
, pp. 162-177
-
-
-
2
-
-
1642345591
-
Trends in the treatment of ductal carcinoma in situ of the breast
-
Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2004;96(6):443-448.
-
(2004)
J Natl Cancer Inst.
, vol.96
, Issue.6
, pp. 443-448
-
-
Baxter, N.N.1
Virnig, B.A.2
Durham, S.B.3
Tuttle, T.M.4
-
3
-
-
0003964363
-
-
American Cancer Society. Atlanta: American Cancer Society. Accessed August 12, 2013
-
American Cancer Society. Cancer Facts & Figures. Atlanta: American Cancer Society; 2008. http://www.cancer.org/research/cancerfactsstatistics/ cancerfactsfigures2008/index. Accessed August 12, 2013.
-
(2008)
Cancer Facts & Figures
-
-
-
4
-
-
84886049860
-
Treatment of ductal carcinoma in situ after excition: Would a prophylactic paradigm be more appropriate?
-
Punglia R, Schnitt S, and Weeks, J. Treatment of ductal carcinoma in situ after excition: would a prophylactic paradigm be more appropriate? J Natl Cancer Inst. 2013;105(20): 1527-1533.
-
(2013)
J Natl Cancer Inst.
, vol.105
, Issue.20
, pp. 1527-1533
-
-
Punglia, R.1
Schnitt, S.2
Weeks, J.3
-
5
-
-
0032490119
-
Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci
-
O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst. 1998;90(9):697-703.
-
(1998)
J Natl Cancer Inst.
, vol.90
, Issue.9
, pp. 697-703
-
-
O'Connell, P.1
Pekkel, V.2
Fuqua, S.A.3
Osborne, C.K.4
Clark, G.M.5
Allred, D.C.6
-
6
-
-
0035860140
-
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness
-
Wärnberg F, Nordgren H, Bergkvist L, Holmberg L. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Br J Cancer. 2010;85(6):869-874.
-
(2010)
Br J Cancer.
, vol.85
, Issue.6
, pp. 869-874
-
-
Wärnberg, F.1
Nordgren, H.2
Bergkvist, L.3
Holmberg, L.4
-
7
-
-
0037361170
-
Molecular markers in ductal carcinoma in situ of the breast
-
Porter D, Lahti-Domenici J, Keshaviah A, et al. Molecular markers in ductal carcinoma in situ of the breast. Mol Cancer Res. 2003;1(5): 362-375.
-
(2003)
Mol Cancer Res.
, vol.1
, Issue.5
, pp. 362-375
-
-
Porter, D.1
Lahti-Domenici, J.2
Keshaviah, A.3
-
8
-
-
0038137601
-
Gene expression profiles of human breast cancer progression
-
Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A. 2003;100(10):5974-5979.
-
(2003)
Proc Natl Acad Sci U S A.
, vol.100
, Issue.10
, pp. 5974-5979
-
-
Ma, X.J.1
Salunga, R.2
Tuggle, J.T.3
-
9
-
-
67549115421
-
The transition from ductal carcinoma in situ to invasive breast cancer: The other side of the coin
-
Schnitt SJ. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin. Breast Cancer Res. 2009;11(1):101.
-
(2009)
Breast Cancer Res.
, vol.11
, Issue.1
, pp. 101
-
-
Schnitt, S.J.1
-
10
-
-
33747095513
-
Do myoephithelial cells hold the key for breast tumor progression?
-
Polyak K, Hu M. Do myoephithelial cells hold the key for breast tumor progression? J Mammary Gland Biol Neoplasia. 2005;10(3):231-247.
-
(2005)
J Mammary Gland Biol Neoplasia.
, vol.10
, Issue.3
, pp. 231-247
-
-
Polyak, K.1
Hu, M.2
-
11
-
-
79952845819
-
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
-
Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2011;103:478-488.
-
(2011)
J Natl Cancer Inst.
, vol.103
, pp. 478-488
-
-
Wapnir, I.L.1
Dignam, J.J.2
Fisher, B.3
-
12
-
-
0033549344
-
Tamoxifen in treatment of intraductal breast cancer: National surgical adjuvant breast and bowel project B-24 randomised controlled trial
-
Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;353:1993-2000.
-
(1999)
Lancet.
, vol.353
, pp. 1993-2000
-
-
Fisher, B.1
Dignam, J.2
Wolmark, N.3
-
13
-
-
79959403574
-
Exemestane for breast cancer prevention in postmenopausal women
-
Goss PE, Ingle JN, Alés-Martínez JE, et al. Exemestane for breast cancer prevention in postmenopausal women. N Engl J Med. 2011; 364(25):2381-2391.
-
(2011)
N Engl J Med.
, vol.364
, Issue.25
, pp. 2381-2391
-
-
Goss, P.E.1
Ingle, J.N.2
Alés-Martínez, J.E.3
-
14
-
-
84874745627
-
Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years afte diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomized trial
-
Davies C, Pan H, Godwin J, et al. Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years afte diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomized trial. Lancet. 2013;381(9869):805-816.
-
(2013)
Lancet.
, vol.381
, Issue.9869
, pp. 805-816
-
-
Davies, C.1
Pan, H.2
Godwin, J.3
-
15
-
-
84878978550
-
ATTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer
-
abstract 5
-
Gray RG, Rea D, Handley K, et al. aTTom: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer. J Clin Oncol. 2013;31(Suppl):abstract 5.
-
(2013)
J Clin Oncol.
, vol.31
, Issue.SUPPL.
-
-
Gray, R.G.1
Rea, D.2
Handley, K.3
-
16
-
-
33644972703
-
Prospective study of wide excision alone for ductal carcinoma in situ of the breast
-
Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24(7):1031-1036.
-
(2006)
J Clin Oncol.
, vol.24
, Issue.7
, pp. 1031-1036
-
-
Wong, J.S.1
Kaelin, C.M.2
Troyan, S.L.3
-
17
-
-
73949085809
-
Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the eastern cooperative oncology group
-
Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27(32):5319-5324.
-
(2009)
J Clin Oncol.
, vol.27
, Issue.32
, pp. 5319-5324
-
-
Hughes, L.L.1
Wang, M.2
Page, D.L.3
-
18
-
-
84877950429
-
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast
-
Solin LJ, Gray R, Baehner FL, et al. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2013;105(10):701-710.
-
(2013)
J Natl Cancer Inst.
, vol.105
, Issue.10
, pp. 701-710
-
-
Solin, L.J.1
Gray, R.2
Baehner, F.L.3
|